Nitrite ion has been identified as the active ingredient of two commercial adulterants that could cause discrepant results between the immunoassay screening and gas chromatographic-mass spectrometric (GC-MS) confirmation of 11-nor-A%tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in urine. Procedures to chemically convert the nitrite ion at the beginning of sample preparation for GC-MS analysis may not overcome all nitrite adulteration cases because portions of the THCCOOH might have been lost between the time of sample collection and the time of analysis. This study was conducted to further investigate the influence of both urine sample matrix and the duration of nitrite exposure on nitrite interference of THCCOOH detection. Forty clinical "THC-positive samples" that had been screened and confirmed positive for the presence of THCCOOH were spiked with 0.15M or 0.3M of nitrite. The levels of THCCOOH at various time intervals after nitrite spiking were monitored by instrument-based cannabinoids immunoassays (Syva EMIT d.a.u, and/or Roche Abuscreen ONLINE assays) and by an onsite THC immunoassay (Roche ONTRAK TESTSTIK). Results from this report demonstrate that the two outstanding "urine specimen factors" that dictated the effectiveness of the nitrite adulteration were urinary pH and the original drug concentration before nitrite spiking. Significant decreases in the immunoassay results could be observed within 4 h of nitrite treatment in the majority of samples with acidic urinary pH values. Regardless of their original concentration of THCCOOH (GC-MS ranging from 33 to 488 ng/mL), all of the 20 samples that had acidic pH values gave negative immunoassay results 1 day after nitrite adulteration. In contrast, the immunoassay results of samples with neutral or basic pH values were less affected by nitrite exposure in the same studies. Approximately two-thirds of the samples with pH values greater than 7.0 remained immunoassay-positive 3 days after nitrite spiking. Nevertheless, some of the adulterated urine that showed no change in immunoassay results might exhibit significant decrease in GC-MS recoveries even with bisulfite treatment, collaborating with the observations that a portion of samples screened positive with THC immunoassay in the laboratory could fail to confirm with GC-MS analysis. The decrease or loss of immunoassay detectable cannabinoid cross-reactives in acidic "THC-positive samples" can be attenuated by chemically increasing the pH value of the samples to the basic pH range.
Introduction
Recent publications have shown that drug use in the U.S. has declined (1), and the positive test results for drugs in the workplace have continued the downward trend (2) . The estimated percentage of American "current illicit drug users" in 1997 was half that of the 1979 peak (1). When The Drug Testing Index {) was established in ]988, 13 .6% of all drug tests were reported as positive. In comparison, during the first six months of 1999, 4.7% of the approximately 2.8 million workplace drug tests performed during the period were reported positive (2) . However, the same report also indicated that cheaters made up a significant portion of those who tested positive. More people tested positive for in vitro and in vivo adulteration than for either opiates or amphetamines. Approximately two-thirds of adulteration involved the use of oxidizing adulterants, including nitrite (2) .
The problem of purposeful adulteration of urine has paralleled with the history of illicit drug testing (3) (4) (5) (6) . Most of the in vitro adulterants were used to bring about a false-negative result in the initial immunoassay drug screening, thus avoiding the gas chromatographic-mass spectrometric (GC-MS) confirmation test. However, nitrite adulteration was uncovered when several laboratories encountered increased incidences of specimens that screened positive for marijuana by immunoassay but failed the GC-MS confirmation test (7) (8) (9) (10) . The commercial adulterants, KLEAR and Whizzies, were identified as potassium nitrite (KNO2) and sodium nitrite (NaNO2), respectively (7, 10) . These products are still being actively advertised in the "beat the test" community. The nitrite adulterants are "easy to use" (dissolved readily) and "hard to detect" (they do not cause a visually discernible change in the physical appearance of the urine specimen) (9) . One report cited that nearly 10% of the specimens that screened positive for cannabinoids in that laboratory contained abnormal amounts of nitrite (11) . Moreover, it is not clear to what extent those screened negative specimens might contain abnormal amounts of nitrite. One recent presentation estimated that nearly 1000 adulterated specimens are submitted to drugtesting laboratories each week (12) .
The recently issued guidance documents for reporting specimen validity test results from the Department of Health and Human Services (HHS) and the Department of Transportation (DOT) permit laboratories to test for sample dilution and adulteration, but do not require the employers/agencies to order such tests (12, 13) . In an evaluation involving the submission of adulterated blind-control samples to 18 different HHS-certified laboratories through a number of companies (12) , the results indicated that only some of the laboratories routinely conducted adulteration tests. Also, many workplace employers have not requested adulteration testing. For that evaluation, samples conraining nitrite were never reported as positive for cannabinoids, perhaps because of significant loss of the cannabinoids in the 24-h transit period to the laboratories (12) .
It has been discussed that the recovery of THCCOOH was urinary pH dependent and could be affected by urine properties (e.g., the presence of particulate matters and naturally occurring reducing agents, etc.), as well as by storage time and conditions (9, 10) . Using reversed-phase high-performance liquid chromatography (HPLC) and negative electrospray mass spectrometry (ES-MS), Lewis et al. (14) observed that nitrite spiking caused the decrease in area counts for the THCCOOH-d3 peak with concomitant formation of an unstable, nitroso-complexed form of THC-COOH-d3. The authors proposed preventing the nitrosation by the addition of potassium carbonate as a buffering agent prior to, or following, sample void to maintain a basic pH in the sample (14) . Realistically, the pH values of normal human urine can range from 5 to 9. Most studies reported so far have depended on the use of standards made from pooled, certified-negative human urine. Although the urine standards allow for wider-scoped investigation and more comprehensive study designs, the pooled urine matrix could not simulate the matrix variation of individual urine specimens. In this study, clinical samples that have been screened and confirmed positive for THCCOOH were used to further investigate the correlation of nitrite-induced THC-COOH instability with urinary pH and the duration of nitrite exposure. The timed study is of interest because the time lag between sample collection and analysis can vary considerably depending on the testing technology. Such time lags can range from a few minutes to a few hours for onsite immunoassay, as compared to from one to several days for laboratory-based immunoassays and GC-MS analysis. Behring, Inc., San Jose, CA) in a qualitative mode according to the manufacturer's instructions (16) . The qualitative ONTRAK TESTSTIK THC assay (50-ng/mL cutoff) was obtained from Roche Diagnostics (17) . The sample (approximately 0.3 mL per test) was directly pipetted to the sample receiving area of this onsite immunoassay device, and the result was visually interpreted 5 rain later. A negative result was indicated by the presence of a horizontal blue band in the result window on the device, and a positive result was indicated by the absence of color in the result window (i.e., a white plus sign). The CHEMSTRIP urine test strips were obtained from Roche Diagnostics.
Urine specimens and controls
Clinical samples that had been screened positive for cannabinoid cross-reactives by the Roche Abuscreen ONLINE immunoassay (based on a 50-ng/mL cutoff) and confirmed positive as containing THCCOOH above the 15-ng/mL cutoff for GC-MS were obtained from a testing laboratory. In all, 40 clinical samples were used for the immunoassay studies (ONLINE and TEST-STIK). However, only six of these samples that contained sufficient volume for extensive investigation were analyzed by all three immunoassay technologies and by GC-MS analysis at various times after nitrite treatment. The selected samples were tested with the CHEMSTRIP 10. The pH values of all specimens were also measured using a pH meter purchased from Beckman Coulter (Fullerton, CA). The samples were then aliquoted and kept frozen at -20~ until the time of the intended study. Urine controls were prepared in pooled, filtered, normal human urine containing 0.09% sodium azide. The urine pool was determined to be drug-free for the DHHS-5 drug panel by both the Abuscreen ONLINE assays and GC-MS analysis. The THCCOOH drug stock solution was added analytically to this urine pool. Drug concentrations in the cutoff (target GC-MS concentration 50 ng/mL) and 2x cutoff (target concentration 100 ng/mL) of the controls were determined to be within * lhr ',amples were tested by ONLINE assay using ,i Hitachi 717 analyzer in a semiquantitative mode at ~.arious times after the spiking of 0.15M potassium r, trlte into the sample. The first evaluation was performed as soon as the nitrite was dissolved in the samples (less than 2 rain). Ihe results ,.,.ere interpreted as nugative relative to a 50-ng/mL cutoff. : Ihe ",anll)les ',;err tested by f Mil assay using an ETS analyzer in a qualitative mode at various times after lhc spiking of [).15M potasqunl nitrite into the sample. Ihe results are expressed as AA = mean absorban(e ol >sted san)pie mean absorbanc.e of the 50-n~mL calibrator, 1he absorban(e rate for the calibrator hinged from 715 to 72fl for lhe duration of this study. " The ONLINE assay value for this "2x THCCOOH urine standard" was 109 ng/mL when tested as "no nitrite control", Aliquots of the standard were spiked with nitrite to reach the final nitrite concentrations as indicated, Samples were tested by both ONLINE assay and EMIT assay at various limes after nitrite spiking, The first evaluation was performed as soon as the nitrite was dissolved in the sample (less than 2 min).
GC-MS analysis
Urine specimens containing an appropriate amount of internal standard (hexadeutero-A9-THCCOOH, EISohly Laboratories) were hydrolyzed and extracted for GC-MS analysis according to the procedure published by E1Sohly et al. (18) . For the bisulfite treatment, 250 mg sodium bisulrite was added to the specimen following the addition of internal standard, and the mixture was allowed to stand for 5 rain prior to extraction (7, 9) . GC-MS analysis was performed using a 10-m x 0.18-rnm DB-1 column (0.4-1Jm film) programmed from 200~ (0.5 rain) to 250~ at 30~ with 8 rain. temperature hold. Helium was used as carrier gas at 45 cm/s, splitless injector at 250~ with a 0.2-rnin delay. The temperature of the transfer line between the GC and the MS was 280~ The ions were monitored at m/z 372,357, and 313 for THCCOOH and at m/z 378, 360, and 319 for the hexadeutero-THC-COOH. The linear range of the GC-MS analysis is from 2 ng/mL to 800 ng/mL. Concentrations of unknown specimens were calculated relative to a calibration curve prepared with 6, 15, and 50 ng/mL THCCOOH with both negative and positive controls.
Results and Discussion

Nitrite-adulterated urine specimens
The adulterant KLEAR is generally supplied as two vials, each containing a solid reagent weighing about 0.5 g that can be added directly to urine. One of the information sheets supplied by a vendor contained the statement that "1 vial of KLEAR will mask the marijuana metabolite panel, and 2 vials of KLEAR will mask the other panels". The adulterant Whizzies is also supplied as two vials, each filled with close to 1 g of white powder. The vendor's direction is to "pour one vial of Whizzies powder into your urine". Therefore, depending on the volume of urine voided, it is estimated that the nitrite concentration in the specimens could range from 0.05M to 0.6M. In two published reports 
ONLINE and EMIT immunoassays
The effect of nitrites on the performance of the immunoassays was first examined by spiking 0.30M of nitrite into six clinical samples with urinary pH in the range of 6.10 to 7.65 (Table I ). The samples were tested immediately after spiking (within 2 rain) and tested five more times for up to 28 h at room temperature. 3~vo samples with pH around 6. In a separate experiment, the same samples 71. 6 were spiked with 0.15M of nitrite, stored at room >100 temperature, and monitored with both ONLINE >lOO and EMIT d.a.u, assays for three days (Table II) cutoff at 28 h after nitrite spiking with ONLINE, 56. 4 and three of those four samples also showed neg-63. 4 aLive EMIT results (relative to a 50-ng/mL cutoff) 71. 6 at 28 h. In addition, these four samples showed >loo negative results for both immunoassays by the >1 oo second day. One day after spiking, the THC assay 75.1 values for these four samples treated with 0.15M >100 61.2 nitrite were actually lower than those treated with 0.30M of nitrite. Such results seem to contradict the expectation that more nitrite would lead to more damage of THCCOOH. Nevertheless, both concentrations were high and the difference between the two nitrite levels may not be significant. The trend of exposure time-related and urinary pH-related decrease of THCCOOH was the same for these two independent studies, and both indicated that certain percent of nitrite-adulterated clinical samples could have lost enough THCCOOH to give negative immunoassay results by the time of laboratory testing.
It is important to point out that some of the samples judged as negative based on a 50-ng/mL cutoff would still be considered positive if a lower cutoff, such as 20 ng/mL, were selected. However, a lower cutoff assay would merely extend the time window that a sample can be reported as positive because the level of THCCOOH will eventually fall below 20 ng/mL if the pH of the sample is in the acidic range.
In a previous study, we used multianalyte standards that had a pH value of 7.50 to study the effect of high nitrite concentrations on the detection of five commonly abused drugs (9) . When the "Ix" (cutoff) standard was treated with 1.0M of nitrite, the ONLINE THCCOOH standard value decreased from 50 ng/mL to 40 ng/mL. For this study, a "2x" standard that had a pH value of 7.90 was spiked with four different levels of nitrite (0.15M, 0.30M, 0.50M, and 1.0M), then assayed for cannabinoid cross-reactives. As shown in Table III , no significant difference was observed with ONLINE assay results although there was some variations between the various testing times. In contrast, the EMIT results were suppressed by 0.5M of nitrite and markedly interfered with by 1.0M of nitrite. This may probably be related to the fact that high concentrations of nitrite dramatically increased the ionic strength and the conductivity of the treated samples (9).
ONLINE and ONTRAK TESTSTIK immunoassays
The quick loss of THCCOOH in the presence of nitrite and an acidic environment has a high probability to cause discrepant screening results because onsite assays are generally performed shortly after sample collection while it takes time to send the sample to laboratories for testing. Nevertheless, the scenario of samples screening positive yet failed to confirm would happen with both laboratory based immunoassays and the onsite immunoassay devices. The six samples were spiked to 0.15M of potassium nitrite and 0.15M of sodium nitrite, respectively, and tested with ONTRAK TESTSTIK at 0.5 h and 28 h post spiking. All tested positive at 0.5 h, but three samples (pH 6.10, 6.15, and 6.70) showed negative results one day later.
In addition to the six clinical samples used for the studies already described, 34 THC-positive clinical samples were spiked to 0.15M of potassium nitrite, stored refrigerated, and monitored over a period of three days with ONLINE immunoassay using a Roche COBAS INTEGRA 700 analyzer. For comparison, the 40 samples were also tested with the ONTRAK TESTSTIK immunoassay for THC at 0 h, 4 h, and 76 h after nitrite spiking.
The 34 samples were screened with ONLINE immunoassay in the order of their assigned sample number (numbers 7 to 40). However, the results were best understood when data were sorted according to the pH value of the samples (as summarized in Table IV ). Rapid declines in the immunoassay values were observed with the 16 acidic samples. Seven of the eight samples with urinary pH values ranging from 5.40 to 5.95 became negative in 2 h postadulteration. Similarly, seven of the eight samples with pH value ranging from 6.24 to 6.86 tested negative in 4 h postadulteration. The reduction of cannabinoid cross-reactives occurred rapidly even though spiked samples were refrigerated until the scheduled time point of testing. In contrast, 4 of 7 "near-neutral" samples (urinary pH ranging from 7.15 to 7.59) and 10 of 11 "basic" samples (urinary pH ranging from 8.09 to 8.91) remained "immunoassay positive" (relative to 50-ng/mL cutoff) at 76 h after the spiking of nitrite. It is interesting to note that many samples with urinary pH values above 7.0 showed a lower recovery of cannabinoid crossreactives at 2 h after nitrite spiking as compared to that at 4 h postadulteration. tain tests for nitrite, pH, and creatinine and glutaraldehyde. In addition, the CHEMSTRIP 10 urine testing system is a multiparameter test strip to measure the following constituents in the urine: nitrite, pH, specific gravity, leukocytes, protein, glucose, ketones, urobilinogen, bilirubin, and blood. The nitrite test is intended for pathological levels of nitrite that are much lower than adulterated levels; however, adulterated urine gives the pad a very dense color that is different than the pink coloration because of nitrite levels derived from natural sources.
GC-MS analysis
The six samples used for ONLINE and EMIT immunoassay studies were also analyzed by GC-MS immediately following and 3 h after nitrite spiking. Without bisulfite treatment, none of the samples analyzed showed any detectable THCCOOH or its internal standard in the nitrite-containing urine. Thus, the impact of nitrite on the GC-MS analysis per se lies on the interference of the procedure that could be affected by the nitrite concentration but appears independent of urinary pH value.
As shown in Table VI , the nitrite interference of GC-MS analysis could be alleviated by treating the samples with bisulfite prior to the addition of internal standard and the sample extraction step for GC-MS analyses. However, even with the bisulfite step, all six samples showed significant reduction in THCCOOH recoveries at 1 h after nitrite spiking. At this time, four of the six samples could still be considered "confirmed positive" by GC-MS. Moreover, only one of the six samples could be considered confirmed at 28 or 76 h after the spiking of nitrite. Interestingly, the decline of GC-MS recovery of THCCOOH from these samples occurred at a much faster rate when compared to the decrease of cannabinoid cross-reactives (as determined with immunoassays). As indicated in Table VI , the GC-MS results for two of the samples (pH 7.23 and pH 7.65) did not agree with their immunoassay results. Both EMIT and ONLINE immunoassays did not detect appreciable reduction of cannabinoid cross-reactives at the same time (e.g., 28 h postspiking) when GC-MS showed approximately 73% to 81% reduction in THCCOOH recovery. In contrast, a"l.2x" THCCOOH standard subjected to the same "bisulfite-GC-MS" analysis did not show the same trend of reduction in THCCOOH recovery. The 1.2x THCCOOH standard contained amount of THCCOOH near the mean GC-MS value of that of the six samples evaluated and therefore was included in the "bisulfite-GC-MS" experiment as a control. Unlike the clinical samples, the urine standard was prepared in pooled normal human urine that had been filtered, preserved, and certified as drug free. * Two clinical samples with acidic pH values were each divided into four aliquots. Three of the four aliquots were adjusted to various target pH ranges using 5M NaOH solution. The adjusted pH value of each aliquot was determined before nitrite spiking. Sample aliquots were tested using Abuscreen ONLINE immunoassay for THC at 4, 28, 76, and 100 h after nilrite spiking, The ONLINE results for the original samples were > 100 ng/mL.
"Chemical manipulation" of effectiveness of nitrite adulteration Lewis et al. was the first to hypothesize that termination of nitroso-THCCOOH formation in nitrite-adulterated drug-screening specimen appears possible through sample pre-or posttreatment with a basic buffer to prevent the N203 formation (14) . Although it appears impractical to add basic buffer to all urine specimens for drug screening, we tested the hypothesis by adjusting the pH value of two acidic, "THC-positive" clinical samples to various pH levels. Because the amount of alkaline buffer needed to raise the pH of acidic samples would result in the dilution of the samples and therefore reducing the "relative THC-acid content" in the specimens, we chose to use 5M NaOH that allowed the adjustment of urinary pH without significantly diluting the samples. After the adjustment of urinary pH to reach the four "normal urine pH levels" (pH 5 to 6, 6 to 7, 7 to 8, and 8 to 9), the samples were spiked with nitrite (0.15M) and evaluated with ONLINE immunoassay at various time intervals. The results tabulated in Table VII demonstrate that the effect of nitrite on cannabinoid cross-reactives could indeed be manipulated by adjusting urinary pH values. There is a trend of urinary pH-dependent reversal of the nitriteinduced loss of cannabinoids over time. However, even samples with basic urinary pH could show substantial decrease of cannabinoid cross-reactives (Table IV) . Additional factors such as the amount of the marijuana metabolites in the sample, or other (currently unrecognized) urine matrix effects, may also influence the outcome of nitrite interference.
